Danavish Trimetazidine 35mg Tablet MR
Prescription Required
Product introduction
Danavish Trimetazidine 35mg Tablet MR is used to treat angina pectoris, a condition marked by chest pain due to reduced blood flow to the heart. It helps the heart work more efficiently by improving how it uses oxygen. It protects heart cells during reduced oxygen supply, helping reduce the number and severity of angina attacks.
Danavish Trimetazidine 35mg Tablet MR should be taken exactly as prescribed by your doctor, usually twice daily with meals. For best results, adopt heart-healthy habits like regular physical activity, quitting smoking, and following a balanced, low-fat diet. Do not skip doses or stop the medicine without medical advice. If you stop taking it, your symptoms may come back.
Common side effects of Danavish Trimetazidine 35mg Tablet MR include dizziness, headache, abdominal pain, or nausea. These side effects are generally mild and temporary. If any symptom persists or worsens, speak to your doctor. Taking the medicine with food may help reduce stomach discomfort.
Danavish Trimetazidine 35mg Tablet MR is not meant for treating sudden chest pain (acute angina). It should not be used in people with Parkinson’s disease, movement disorders, or severe kidney problems. Avoid driving or using machinery if you feel dizzy or unsteady while taking this medicine. Always inform your doctor about any other medications or health conditions you have.
Uses of Danavish Tablet MR
Benefits of Danavish Tablet MR
In Angina (heart-related chest pain)
Angina occurs when the heart doesn't get enough oxygen-rich blood, leading to chest discomfort. Danavish Trimetazidine 35mg Tablet MR helps improve the heart’s efficiency during low oxygen conditions, which can reduce the frequency and intensity of angina attacks and support better daily functioning.
In Heart Failure
In heart failure, the heart struggles to pump blood effectively. Danavish Trimetazidine 35mg Tablet MR can support heart energy metabolism, helping the heart work more efficiently. This may lead to improved exercise tolerance, reduced symptoms like fatigue or breathlessness, and a better quality of life.
Side effects of Danavish Tablet MR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Danavish
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Diarrhea
- Rash
- Abdominal pain
- Indigestion
- Itching
- Red spots or bumps
How to use Danavish Tablet MR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Danavish Trimetazidine 35mg Tablet MR is to be taken with food.
How Danavish Tablet MR works
Danavish Trimetazidine 35mg Tablet MR is an anti-anginal medication. It decreases the oxygen requirement of the heart by shifting its metabolism from fats to glucose. As a result, the heart works more efficiently.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Danavish Trimetazidine 35mg Tablet MR. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Danavish Trimetazidine 35mg Tablet MR during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Danavish Trimetazidine 35mg Tablet MR during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
Danavish Trimetazidine 35mg Tablet MR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Danavish Trimetazidine 35mg Tablet MR should be used with caution in patients with kidney disease. Dose adjustment of Danavish Trimetazidine 35mg Tablet MR may be needed. Please consult your doctor.
Use of Danavish Trimetazidine 35mg Tablet MR is contraindicated in patients with severe kidney disease.
Use of Danavish Trimetazidine 35mg Tablet MR is contraindicated in patients with severe kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Danavish Trimetazidine 35mg Tablet MR in patients with liver disease. Please consult your doctor.
What if you forget to take Danavish Tablet MR?
If you miss a dose of Danavish Trimetazidine 35mg Tablet MR, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Danavish Trimetazidine 35mg Tablet MR
₹5.42/Tablet MR
Flavedon MR Tablet
Servier India Private Limited
₹16.7/tablet mr
208% costlier
Trivedon MR Tablet
Cipla Ltd
₹21.2/tablet mr
291% costlier
Cytohope 35mg Tablet MR
Conatus Healthcare Pvt. Ltd.
₹15.2/tablet mr
180% costlier
Angidine Retard Tablet MR
Synmedic Laboratories
₹8.19/tablet mr
51% costlier
Trinol 35mg Tablet MR
Knoll Pharmaceuticals Ltd
₹6.39/tablet mr
18% costlier
Quick tips
- Take Danavish Trimetazidine 35mg Tablet MR with food to reduce the chance of stomach upset and improve absorption.
- Take it regularly at the same time each day for best results and don’t skip doses.
- Do not use for sudden chest pain (acute angina attacks); it is meant for long-term management.
- Avoid driving or operating machinery if you feel dizzy or unsteady while on this medicine.
Fact Box
Chemical Class
Phenylmethylamines
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Fatty Acid Oxidation Inhibitors
Patient concerns
FAQs
Is Danavish Trimetazidine 35mg Tablet MR a beta blocker?
No, Danavish Trimetazidine 35mg Tablet MR is not a beta blocker. It is an anti-anginal medicine used in combination with other medicines to treat angina pectoris (chest pain caused by coronary disease). It protects the heart cells from being affected by the reduced oxygen supply during an episode of angina.
Who should not take Danavish Trimetazidine 35mg Tablet MR?
Individuals who are allergic to trimetazidine or have severe kidney problems should not take Danavish Trimetazidine 35mg Tablet MR. Patients with Parkinson’s disease should also avoid taking the medicine. Parkinson’s disease is a disease of the brain that affects movement and causes trembling, rigid posture, slow movements, and a shuffling, unbalanced walk.
Can Danavish Trimetazidine 35mg Tablet MR be used in elderly patients?
Danavish Trimetazidine 35mg Tablet MR should be used with caution in patients aged more than 75 years of age. Usually, a lower dose is prescribed in elderly patients to reduce the chances of adverse effects. It is important to continuously monitor such patients.
Does taking Danavish Trimetazidine 35mg Tablet MR increase the risk of falling frequently?
Though it is rare, falls may occur with the use of Danavish Trimetazidine 35mg Tablet MR. This may be due to instability while walking or a fall in blood pressure while standing up. The risk may be higher in elderly patients. Therefore, they need to be more careful and should be monitored.
Does Danavish Trimetazidine 35mg Tablet MR cause drowsiness?
Yes, Danavish Trimetazidine 35mg Tablet MR may make you feel dizzy and drowsy. Therefore, you should avoid driving or using heavy machinery in case it causes these side effects.
How should Danavish Trimetazidine 35mg Tablet MR be taken?
You should take Danavish Trimetazidine 35mg Tablet MR exactly as prescribed by your doctor. Take it with a sufficient amount of liquid, e.g., a glass of water.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- CiplaMed. Trimetazidine dihydrochloride [Prescribing Information]. [Accessed 29 Apr. 2025]. (online) Available from:
- Trimetazidine [Summary of Product Characteristics]. Suresnes, France: Les Laboratoires Servier; 2021. [Accessed 29 Apr. 2025]. Available from:
- Ciapponi A, Pizarro R, Harrison J. WITHDRAWN: Trimetazidine for stable angina. Cochrane Database Syst Rev. 2017 Mar 20;3(3):CD003614. Accessed 29 Apr. 2025]. (online) Available from:
- MIMS, Philippines: Trimetazidine [Generic Medicine Information]. [Accessed 29 Apr. 2025]. (online) Available from:
- Trimetazidine dihydrochloride [Prescribing Information]. Indrad, Mehsana: Torrent Pharmaceuticals Ltd. [Accessed 29 Apr. 2025]. (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
Marketer details
Name: Danavish Healthcare
Address: Vetturnimadam Nagercoil ,Tamil Nadu
Country of origin: India
Lab tests offered by us
Related/Popular tests
₹54.2
Inclusive of all taxes
MRP₹60 10% OFF
10.0 tablet mr in 1 strip
SOLD OUT